FDA — authorised 22 June 1998
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: approved
🇺🇸 Priftin in United States
FDA authorised Priftin on 22 June 1998
Marketing authorisations
FDA — authorised 22 June 1998
- Application: NDA021024
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: PRIFTIN
- Indication: TABLET — ORAL
- Status: approved
Priftin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Priftin approved in United States?
Yes. FDA authorised it on 22 June 1998; FDA authorised it on 22 June 1998.
Who is the marketing authorisation holder for Priftin in United States?
SANOFI AVENTIS US holds the US marketing authorisation.